Schoenberg Mark
UroGen Pharma Ltd. · Chief Medical Officer
Schoenberg Mark is listed in filings as Chief Medical Officer at UroGen Pharma Ltd.. This profile follows SEC Form 4 activity through Jun 24, 2026, including sale activity. Recent filings connect the profile to UroGen Pharma Ltd. (URGN). The current snapshot covers public activity from Jun 11, 2024 to Jun 24, 2026. Reported amounts are shown as $350.1K to $11.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $350k10k shares | SellJun 22, 2026 | $35.01 | $39.81 |